Form 4 holding
Director
TITAN PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 66,250
- Estimated value
- $81,488
- Report date
- 25 Oct 2023
- Price
- $1.23
- Ownership
- Direct
David Natan - Director at TITAN PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- TTNP
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by David Natan since 16 Aug 2025
Reported holdings for David Natan in TITAN PHARMACEUTICALS INC
Form 4 holding
Director
TITAN PHARMACEUTICALS INC
- Security class
- Option to Purchase Common Stock
- Shares / value
- 100,000
- Estimated value
- Report date
- 29 Jun 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for David Natan in TITAN PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.